AMY EDDY: Open Payments
NPI 1548220486 · BELPRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 37 payments from 16 companies in 2025. Trend: 2023 $308 · 2024 $691 · 2025 $749
Food & beverage: $733Education: $16
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $133 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| ABBVIE INC. | 3 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| ARRAY BIOPHARMA INC | 3 | $47 |
| Eisai Inc. | 2 | $44 |
| Aveo Pharmaceuticals, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 1 | $31 |
| Stemline Therapeutics Inc. | 1 | $27 |
| SERVIER PHARMACEUTICALS LLC | 1 | $23 |
Products named: IMBRUVICA, XTANDI, KISQALI, XALKORI, Lenvima, FOTIVDA, PLUVICTO, ELREXFIO.
Industry payments across OH — which companies pay providers there.
